Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Ambulatory Outpatient Management of patients with low risk febrile neutropaenia

Cooksley, T.; Holland, M.; Klastersky, J.

Acute Medicine 14(4): 178-181

2015

ISSN/ISBN: 1747-4892
PMID: 26726789
Document Number: 16196
Patients with febrile neutropenia are a heterogeneous group with only a minority developing significant medical complications. Scoring systems, such as the Multinational Association for Supportive Care in Cancer (MASCC) score, have been developed and validated to identify low risk patients. Caring for patients with low risk febrile neutropenia in an ambulatory setting is proven to be safe and effective. Benefits include admission avoidance, cost savings and reduced risk of nosocomial infections, as well as improved patient experience and satisfaction. Implementation of an ambulatory pathway for low risk febrile neutropenia provides an excellent opportunity for Acute Physicians and Oncologists to collaborate in delivering care for this group of patients.

Document emailed within 1 workday
Secure & encrypted payments

Ambulatory Outpatient Management of patients with low risk febrile neutropaenia

Carstensen, M.; Sørensen, J.B. 2008: Outpatient management of febrile neutropenia: time to revise the present treatment strategy Journal of Supportive Oncology 6(5): 199-208
Ghosh, K. 1996: Immune neutropaenia: diagnosis natural history, clinical features and management Indian Journal of Medical Sciences 50(5): 144-154
Gipponi, M.; Frascio, M.; Arnulfo, G.; D'Aquila, A. 1995: The computerized outpatient management of subjects at neoplastic risk Minerva Medica 86(4): 149-157
Deangelis, C.; Joffe, A.; Willis, E.; Wilson, M. 1983: Hospitalization v outpatient treatment of young, febrile infants American Journal of Diseases of Children 137(12): 1150-1152
Inagaki, M.; Sato, J.; Nihei, S.; Kashiwaba, M.; Kudo, K. 2016: Efficacy of Levofloxacin Hydrate in Febrile Neutropenia for Outpatient Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(5): 593-596
Stahel, H.U. 1999: Ambulatory drainage of lymphedema--possibilities and limits of ambulatory management of patients with lymphedema Wiener Medizinische Wochenschrift 149(2-4): 98
Bagatin, J.; Sardelić, S.; Rumboldt, Z.; Korljan, B.; Naranca, M.; Pivac, N.; Simunić, M. 1993: Outpatient approach to arterial hypertension: analysis of ambulatory care of hypertonic patients at the Clinical Hospital Center in Split 1988-1990 Lijecnicki Vjesnik 115(1-2): 30-34
Batt, N.M.; Radford, A.; Milinis, K.; Asha, S. 2020: Correlating pulmonary embolism severity with short term mortality to risk stratify for outpatient management Acute Medicine 19(2): 69-75
Sie, P.; Bouget, J.; Boulain, T.; Castot, A.; Dumarcet, N.; Druais, P-Louis.; Gruel, Y.; Helft, G.; Huas, D.; Iung, B.; Laroche, J-Pierre.; Leger, P.; Mahe, I.; Pavie, A.; Pelladeau, A.; Roy, P-Marie.; Samama, C-Marc. 2008: Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting--April 2008 Journal des Maladies Vasculaires 33(4-5): 202-213
Schlager, T.A.; Lohr, J.A. 1993: Urinary tract infection in outpatient febrile infants and children younger than 5 years of age Pediatric Annals 22(8): 505-509
Obukh, I.B.; Sokol'skiĭ, A.S.; Filiptsev, P.I.; Rostoshinskiĭ, A.V.; Kazarov, A.R. 1990: The outpatient management of patients with a transplanted kidney Terapevticheskii Arkhiv 62(6): 95-98
Hanada, N.; Tanaka, S.; Takahata, T.; Sato, A. 2014: Use of granulocyte-colony stimulating factor(G-CSF)in patients with cancer at high risk of febrile neutropenia on the basis of high age and complications, recommendations for patients receiving radiotherapy, and adverse events because of G-CSF Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(6): 702-706
Lebeau, B.; Grillot, R.; Michallet, M.; Goullier-Fleuret, A.; Corront, B.; Bru, J.P. 1987: Deep candidiasis in agranulocytic patients: mycological and serological surveillance in 91 febrile episodes and management of an antifungal and antibacterial protocol Annales de Biologie Clinique 45(5): 582-587
Pereira, C.A.P.; Petrilli, A.S.ér.; Carlesse, F.A.; Luisi, F.áv.A.V.; da Silva, K.át.V.ôn.T.B.; de Martino Lee, M.L.úc. 2009: Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison Journal of Microbiology Immunology and Infection 42(2): 141-147
Gibson, J.; Johnson, L.; Snowdon, L.; Joshua, D.; Young, G.; MacLeod, C.; Iland, H.; Vincent, P.; Kronenberg, H. 1994: A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases International Journal of Hematology 60(2): 119-127
Junod, A. 2015: Risk scores for the development of venous thromboembolism in ambulatory patients and in patients hospitalized for acute medical disease Revue Medicale Suisse 11(492): 2030-2036
2013: How does management of echocardiography affect use across risk groups? UM for outpatient discretionary echocardiography appeared to reduce testing rates significantly Managed Care 22(11): 34-43
Karthaus, M.; Meran, J.G.; Geissler, R.G.; Böhme, A.; Jürgens, H.; Ganser, A. 1998: Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia Wiener Medizinische Wochenschrift 148(18): 427-432
Meisel, S.; Terry, P.E. 1984: Pain-management program for ambulatory patients American Journal of Hospital Pharmacy 41(5): 877
Zapata Cervera, R.; Rodríguez Garciá, A. 1982: Problems in the management of ambulatory patients with convulsions Boletin Medico del Hospital Infantil de Mexico 39(7): 502-506